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Abstract This paper reports the results of a questionnaire-based survey of pancreatic surgi-
cal specialists in the United Kingdom addressing aspects of staging, resection volume and out-
come.
A postal survey was undertaken of the 517 members of the Association of upper Gastrointes-
tinal Surgeons of Great Britain and Ireland (AUGIS). 57 surgeons undertook pancreatic resection
from 162 overall respondents. Cross-checking with the list of members of the Pancreatic Soci-
ety of Great Britain and Ireland yielded 64 pancreatic surgeons. 734 pancreaticoduodenectomy
(PD) were reported by respondents compared with 822 procedures according to Government
maintained Hospital Episode Statistics.
The modal resection volume performed per annum was 6e10. There were 24 in-hospital
deaths in 732 resections (3%) mortality. For individual respondents the modal percentage mor-
tality was 5% (0 to 16%). All clinicians with mortality rates in excess of 10% did less than 10 re-
sections per annum. Respondents favoured ‘‘amylase rich discharge beyond 7th post-operative
day’’ as optimal for definition of post-resection pancreatic fistula.
Accepting the limitations of questionnaire surveys, the results provide an important over-
view of pancreatic surgical practice: pancreaticoduodenectomy is carried out by a range of
specialists, lower volume resectionists appear to have poorer outcomes and this study shows
widespread agreement on optimum terminology for post-operative pancreatic fistula.
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Pancreatic cancer is an important health care problem. In
the United Kingdom, pancreatic cancer is the 6th most
common cancer with an incidence of 12 per 100,000.1 As
the number of new registrations per annum is equivalent
to the number of deaths, the overall survival remains in
the order of 12 months from time of diagnosis.1 Further,shed by Elsevier Ltd. All rights reserved.
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incidence.2 Surgical resection is the only treatment that
is associated with prolonged survival.2 There is evidence
that outcome after pancreatic cancer surgery is better in
specialist, high-volume units which report operative mor-
tality rates of less than 5%.3e8 In the United Kingdom, as
in many other countries, this evidence has led to a drive
towards concentration of pancreatic cancer surgery in
specialist units. However, despite this specialisation there
remains no general consensus on many aspects of manage-
ment including optimal disease staging pathways and the
role of pre-operative biliary drainage. Critically, this varia-
tion in practice may extend to details of the operative
conduct of pancreaticoduodenectomy and to the use of
terminology defining peri-operative complications.
This paper reports the results of a path finding ques-
tionnaire-based survey addressing aspects of practice
volume, resection volume and outcome. The ‘‘snap-shot’’
questionnaire approach is also utilised to obtain views
on technical aspects of pancreaticoduodenectomy and
preferred terminology for post-operative complications.
Methods
Study design and population
A postal questionnaire survey was undertaken in 2005 of the
517 members of the Association of Upper Gastrointestinal
Surgeons of Great Britain and Ireland (AUGIS). AUGIS is the
principal forum in the United Kingdom for surgeons with
a declared interest in upper gastrointestinal surgery.
Written permission was obtained from the president of
AUGIS in order to gain access to the membership database
and to circulate questionnaires. The questionnaires were
bundled together with the quarterly AUGIS newsletter. The
study was closed for recruitment 8 weeks after the date of
the mailshot. A total of 162 questionnaires were returned
yielding a response rate among participating clinicians of
31%. Of these 162 respondents, 57 surgeons stated that
they undertook pancreatic resection. This figure was
cross-checked with the list of members of the Pancreatic
Society of Great Britain and Ireland. The Pancreatic Society
membership is comprised of individuals with a declared in-
terest in diseases of the pancreas and thus includes physi-
cians, basic scientists and other interested groups in
addition to surgeons. However, male surgeon members
are denoted by the suffix ‘‘Mr’’ and their declared affilia-
tion to a department of surgery while female surgeons
were identified by their suffix Ms/Miss or Mrs. Using these
cross-checks, a total of 64 pancreatic surgeons were identi-
fied from the Pancreatic Society membership of 265. The
senior author of this study was excluded from participation.
A further cross-check was carried out by comparing the
summated numbers of pancreaticoduodenectomy (PD) pro-
cedures stated as being carried out by respondents with Data
from Hospital Episode Statistics (HES). A total of 734 PD were
reported by respondents to this questionnaire (for the
calendar year 2004). This compares with 822 PD procedures
for the financial year 2003/2004 for NHS hospitals in England
according to HES9 (it should be noted that according to HES 1
of 822 PD was carried out as a day case).Questionnaire design and analysis
This is a four part questionnaire designed to obtain a
‘‘snapshot’’ overview of aspects of clinical practice in
pancreatic cancer. The four components are listed sepa-
rately as follows:
1. Clinical profile questions: clinical practice parameters
such as case volume per clinician, specialist interest
of clinicians and their in-hospital mortality for the cal-
endar year 2004 from pancreaticoduodenectomy.
2. Staging investigation questions: assess the role of stag-
ing investigations in pre-operative assessment.
3. Technical (operative details): to identify routine proce-
dural steps during and prior to pancreaticoduodenec-
tomy such as laparoscopy/laparoscopy ultrasound prior
to surgery, intra-operative frozen sections from tumour,
preferred technique for restoration of pancreatic duct-
enteric continuity, and definitions used for pancreatic
fistula. This last category has proved particularly prob-
lematic as there is no generally agreed standardised def-
inition for post-operative pancreatic fistula.10,11
4. Aspects of post operative care: to investigate practice
in referral for chemotherapy after surgery, methods
of surveillance for tumour recurrence after resection
and also to seek information on the registering of out-
come results in a national register.
All results were anonymised for collation and analysis.
The study was closed for recruitment 8 weeks after the
date of mailshot. Responses to questionnaires were tran-
scribed onto an electronic database (Microsoft Excel, Micro-
soft Corporation, Redmond WA) for analysis.
Ethical approval
The study was approved by the Central Manchester Re-
search Ethics Committee and registered as a full clinical
study with the Research and Development (R&D) office of
the Manchester Royal Infirmary.
Results
Clinical profile
There was considerable variation in the terminology used
by surgeon respondents to describe themselves. Fifteen
(26%) used the term HPB  transplant surgeon with the sec-
ond most frequently stated category being General Surgeon
with HPB interest (10 surgeons [18%]). Table 1 shows the re-
sponses categorised by whether or not surgeons carried out
pancreaticoduodenectomy.
Case volume
The total number of pancreaticoduodenectomy procedures
done by all respondents is 734.
The modal case volume performed per annum by re-
spondents was 6e10 procedures (Fig. 1). Thirteen (23%) re-
spondents undertook more than 15 procedures each per
annum and 1 undertook more than 25.
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Terminology used by surgeons to define their practice Number performing PD Number not performing PD Total
Pancreatic & biliary surgeon 1 0 1
Hepatopancreatobiliary (HPB) surgeon 1 0 1
Hepatobiliary (HB)  transplant surgeon 4 2 6
Pancreatic surgeon 9 0 9
Hepatopancreatobiliary  transplant 15 0 15
Oesophagogastric (OG) surgeon 4 41 45
General surgeon 1 14 15
Gastrointestinal surgeon 8 19 27
General with HPB interest 10 7 17
General with OG interest 4 22 26
Total 57 105 162
PD, pancreaticoduodenectomies.In-hospital mortality
There were 24 in-hospital deaths in 732 resections (3%)
mortality. For individual respondents the modal percentage
mortality was 5% with a range from 0 to 16%. All clinicians
with operative mortality rates in excess of 10% did less than
10 resections per annum.
Staging investigations
Contrast CT is used by all respondents. Endoscopic ultra-
sound is utilised by 27 (47%). A similar percentage utilised
laparoscopy routinely (27 [40%]) with a further 4 (7%) using
laparoscopy selectively. Laparoscopic ultrasonography was
used routinely by 11 (19%) and selectively by 4 (7%). Positron
emission tomography (PET) was used routinely by 2 (4%). No
respondents utilised selective mesenteric angiography.
Pre-operative biliary drainage
Pre-operative biliary drainage was undertaken routinely by
29 (51%). Twenty-six respondents (45%) did not routinely
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Figure 1 Case volume per annum (2004). Number of pan-
creaticoduodenectomies performed by respondents in the
year 2004. Note that the numbers are grouped as 1e5, 6e10,
11e15 procedures.drain an obstructed biliary tree and two surgeons did not
respond to this question.
Delay to resection
The available responses were categorised as follows: 0e
1 week, 1e2 weeks, 2e4 weeks and more than 4 weeks.
The modal response, selected by 21 (37%) was 2e4 weeks.
Of note, 34 (60%) have waiting times in excess of 2 weeks
prior to resection.
Procedural steps in pancreaticodoudenectomy
The preferred options when performing pancreaticoduode-
nectomy are seen in Table 2.
Table 2 The procedural steps undertaken by clinicians
during pancreaticoduodenectomy
Component procedure Routine Percentage
(55 respondents)
Cholecystectomy 53 96
Intra-operative frozen
section of tumour
6 11
Intra-operative frozen section
pancreatic transection margin
10 6
Intra-operative frozen section
of other resection margin
7 13
Excision of station 8
lymph node
36 66
Pancreatic reconstruction by
pancreatico-gastrostomy
3 5
Pancreatic reconstruction by
pancreatico-jejunostomy
52 95
Feeding jejunostomy 20 36
Feeding/decompressing
gastrostomy
4 7
NJ feeding tube 10 6
NJ, nasojejunal.
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A range of descriptors was made available for definition of
post-pancreaticoduodenectomy pancreatic fistula (Table 3).
The majority of respondents favoured the use of the defini-
tion of pancreatic fistula as used in the current dataset of
the Association of Upper Gastrointestinal Surgeons.
Post-resection surveillance
After resection 53 (93%) referred patients for an oncological
assessment. The most frequently used methods for post-
resection surveillance were serial CT combined with
measurement of carbohydrate antigen (CA 19-9). Only 1
respondent used ultrasonography in follow-up.
Role of a national register for
pancreaticoduodenectomy
21 (37%) respondents currently register their results in some
form of national register. Forty-eight (84%) were in favour
of a national database of pancreatic resection.
Service improvements
Access to EUS for pre-operative staging was the most sought
after service improvement (18 respondents [32%]). The
second-most widely sought service was access to PET (13
[23%]). Six respondents wanted access to laparoscopic
ultrasonography whilst faster access to CT and or High
Dependency beds was listed by 3.
Discussion
It is acknowledged that the results of questionnaire surveys
can be profoundly influenced by many factors, in particular
an incomplete response, idealised answers from clinicians
and preferential response by participants and the limited
statistical power of questionnaire surveys. Any or all of
Table 3 Current nomenclature used by clinicians for the
identification of post-operative pancreatic fistula
Definition of pancreatic fistula11 Number of
respondents (%)
>10 ml/day at or after
the 5th post-operative day
3 (5%)
>10 ml/day at or after
the 8th post-operative day
0
>25 ml/day at or after
the 8th post-operative day
4 (7%)
>50 ml/day at or after the
11th post-operative day
2 (4%)
Amylase rich discharge (>3
serum amylase) beyond 7th
post-operative day (current
AUGIS dataset definition)
47 (83%)
AUGIS, Association of Upper Gastrointestinal Surgeons in UK and
Ireland.these factors may have influenced the results of the
present survey. Further, the results should not be regarded
as representative either of the views of any professional
organisation or of the general body of pancreatic surgical
specialists in the United Kingdom.
However, if these caveats are borne in mind, the
present study provides a unique overview of the current
practice of pancreatic cancer surgery in the United
Kingdom. First, it is clear that there is no ready definition
of a pancreatic surgical specialist e even when surgeons
are invited to define themselves in their own words-
there is considerable variation. Clinical profile of sur-
geons highlights the current variation of surgeons who
carry out pancreaticoduodenectomies which is a proce-
dure ideally carried out in specialist centres. The De-
partment of Health estimates that 1 pancreatic surgeon is
required for a population of between 2 and 4 million
people.1 Using the lower figure (2 million), there should
be 30 pancreatic surgeons. It is accepted that this survey
will not have sampled all pancreatic surgical specialists
but cross-checking the AUGIS membership with that of
the Pancreatic Society would suggest a high response
rate. Similarly, comparison of the ‘‘claimed’’ total of
734 pancreaticoduodenectomy procedures with the 822
reported through HES suggests good capture. It should
be emphasised that HES is not an absolutely reliable
gold standard.
Viewed in this context, it is of interest that the major
categories of respondent were HPB  transplant followed
by pancreatic surgeon. Similarly, it could be argued that
in the current National Health Service, specialist pancreatic
surgery should no longer be carried out by a ‘‘Gastrointesti-
nal Surgeon’’ e albeit an individual who is a member of
AUGIS.
Ideal case volume for pancreatic cancer resection has
been exhaustively addressed. Yet, it is interesting that even
in this self-declared response rate study, the highest
mortality rates were seen in the practices of clinicians
with the lowest resection volumes. It could be argued that
the overall good outcomes from pancreatic cancer re-
section in the UK ‘‘mask’’ the outcomes of less successful
surgeons.
Lack of technical standardisation of the procedure
commonly referred to as the Whipple pancreaticoduode-
nectomy has been acknowledged for some time e for
example should patients have cholecystectomy? The results
of this survey show concordance in important areas of
practice: cholecystectomy, separate sampling of the sta-
tion 8 lymph node and reconstruction techniques seem
relatively standardised. Evidence in favour of pancreatico-
gastrostomy over pancreaticojejunostomy12 appears not to
have been adopted in British practice.
The results in terms of definition of pancreatic fistula
are perhaps the most important findings of this study. It can
be stated that this survey of self-stated pancreatic surgical
specialists has, for the first time, found a national consen-
sus in the preferred terminology for pancreatic fistula. This
definition strongly supports the AUGIS minimum dataset.
There is potential for bias as the AUGIS dataset definition
was sent to AUGIS members.
In terms of access to better facilities, EUS was the most
widely sought e reflecting a national trend in the UK.13
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be interpreted with caution as bias can be introduced by
a host of factors and further studies are needed to reach
validated conclusions. Accepting these limitations, the
results provide an important overview of pancreatic surgi-
cal practice: pancreaticoduodenectomy is still carried out
by a range of surgical specialists, surgical outcomes are
good (but lower volume resectionists appear to have poorer
outcomes), the operative technique seems relatively-well
standardised and there is widespread agreement of the
optimum terminology for definition of a post-operative
pancreatic fistula. Overall, the findings provide a unique
insight into current surgical management of pancreatic
cancer in a large, industrialised, Western European
economy.
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